Neuroendocrine mechanisms in chronic perceived stress: Associations with the metabolic syndrome

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 4, 1997, Pages 247-254

  Räikkönen, Katri ^a   Keltikangas Järvinen, Liisa ^a   Hautanen, Aarno ^a   Adlercreutz, Herman ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CORTICOTROPIN; CORTODOXONE; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; STEROID 21 MONOOXYGENASE; THYROGLOBULIN;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CHRONIC DISEASE; DYSLIPIDEMIA; FATIGUE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOPHYSIS ADRENAL SYSTEM; IRRITABILITY; MALE; NEUROENDOCRINOLOGY; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; STRESS;

EID: 0030779211     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Defronzo RA, Ferrannini E. Insulin resistance. A multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 174-194.
2. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haem 1993; 70: 138-143.
3. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1141.
4. Björntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? J. Intern. Med. 1991; 230: 195-201.
5. Bouchard C, Despres J-P, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr. Rev. 1993; 14: 72-93.
6. Shively CA, Clarkson TB. Regional obesity and coronary atherosclerosis in females: a non-human primate model. Acta Med. Scand. 1988; 723 (Suppl.): 71-78.
7. Rebuffe-Scrive M, Walsh UA, McEwen B, Rodin J. Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism. Physiol. Behav. 1992; 52: 583-590.
8. Lapidus L, Bengtsson C, Hällström T, Björntorp P. Obesity, adipose tissue distribution and health in women - results from a population study from Gothenburg, Sweden. Appetite 1989; 12: 25-35.
9. Räikkönen K, Hautanen A, Keltikangas-Järvinen L Association of stress and depression with regional fat distribution in healthy middle-aged men. J. Behav. Med. 1994; 17: 605-616.
10. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantiga P. Waist to hip ratio in middle-aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler. Thromb. 1991; 11: 1250-1257.
11. Räikkönen K, Keltikangas-Järvinen L, Hautanen A. The role of psychological coronary risk factors in insulin and glucose metabolism. J. Psychosom. Res. 1994; 38: 705-713.
12. Räikkönen K, Lassila R, Keltikangas-Järvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler. Thromb. Vasc. Biol. 1996; 16: 363-367.
13. Räikkönen K, Keltikangas-Järvinen L, Hautanen A, Adlercreutz H. Psychosocial stress and the insulin resistance syndrome. Metabolism 1996; 45: 1533-1538.
14. Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J. Intern. Med. 1993; 234: 461-469.
15. Hautanen A, Adlercreutz H. Pituitary adrenocortical function in abdominal obesity of males: evidence for a partial 21-hydroxylase deficiency. J. Steroid Biochem. Molec. Biol. 1996; 58: 123-133.
16. Hautanen A, Räikkönen K, Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinemia and dyslipidemia in normotensive males. J. Intern. Med. (in press).
17. Brindely DN. Neuroendocrine regulation and obesity. Int. J. Obes. 1992; 16 (Suppl. 3): S73-S79.
18. 2+/dextran sulphate in enzymic measurement. Clin. Chem. 1972; 18: 499-502.
19. Kluft C, Verheijen JH. Leiden fibrinolysis working party: blood collection and handling procedures for assessment of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1). Fibrinolysis 1990; 4 (Suppl. 2): 155-161.
20. Appels A. Loss of control, vital exhaustion and coronary heart disease. In: A Steptoe, A Appels, editors. Stress, Personal Control and Health. Brussels: John Wiley & Sons Ltd., 1989; 215-235.
21. Appels A, Mulder P. Fatigue and heart disease. The association between vital exhaustion and past, present and future coronary heart disease. J. Psychosom. Res. 1989; 33: 727-738.
22. Appels A, Falger PR, Schouten EGW. Vital exhaustion as a risk indicator for myocardial infarction in women. J. Psychosom. Res. 1993; 37: 881-890.
23. Kop WJ, Appels APWM, Mendes de Leon CF, de Swart HB, Bär FW. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom. Med. 1994; 56: 281-287.
24. Selye H. The general adapation syndrome and the diseases of adaptation. J. Clin. Endocrinol. 1946; 6: 117-230.
25. Henry JP, Stephens PM. Stress, Health and the Social Environment. A Sociobiologic Approach to Medicine. New York: Springer-Verlag, 1977.
26. SAS Institute Inc. 1992 SAS® User's Guide: Basics, Version Ed. 2. Cary NC: Sas Institute Inc.
27. Bollen KA. Structural equations with latent variables. New York: John Wiley & Sons, Inc., 1989.
28. Brindley DN, Rolland Y. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sci. 1989; 77: 453-461.
29. Demitrack MA, Dale JK, Strauss SE, Lane L, Listwak SJ, Kruesi MJP, Chronosos GP, Gold PW. Evidence for impaired activations of hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrin. Metab. 1991; 73: 1224-1234.
30. Fava GA, Morphy MA, Molnar G, Perini GI. Hypothalamicpituitary-adrenal axis hypoactivity in depressive illness. IRSC Med. Sci. 1985; 12: 954-955.
31. Cleghorn RA. Adrenal cortical insufficiency. Can. Med. Ass. J. 1951; 65: 449-454.
32. Munck A, Naray-Fejes-Toth A. The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited. Mol. Cell. Endocr. 1992; 90: C1-C4.
33. Rose RM. Psychoendocrinology. In: Wilson JO, Foster DW, editors. Williams Textbook of Endocrinology. Philadelphia: WB Saunders Company, 1985: 652-681.
34. Dunn AJ, Kramercy NR. Neurochemical responses in stress. Relationships between the hypothalamic-pituitaryadrenal and catecholamine systems. In: Iverson LL, Iverson DS, Snyder SH, editors. Handbook of Psychopharmacology. New York: Plenum Press, 1984: 455-515.
35. Henry JP. Biological bases of stress response. Integr. Physiol. Behav. Sci. 1992; 27: 66-83.
36. Fontbonne AM, Escwege EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 1991; 14: 461-469.